Procter & Gamble Company (PG) Financial Statements

Procter & Gamble's financial quality is anchored by world-class profitability metrics. An ROE of 31.6% far exceeds the framework's 15-20% high-quality threshold, indicating superb returns on shareholder capital. Operating margins are robust at 24.3%, and the profit margin of 19.3% suggests significant pricing power and cost control. Free cash flow generation is a key strength, with a 4.2% FCF yield providing ample fuel for dividends and share repurchases. The balance sheet is healthy, with a Debt/Equity ratio of 0.66, which is manageable for a stable cash-generating business and below the framework's cautionary level of 1.0x Debt/EBITDA. However, growth is the primary concern. Revenue growth of just 1.5% YoY is minimal and does not meet the framework's criteria for consistent, double-digit, or accelerating growth. This low-growth trajectory places greater emphasis on valuation and margin sustainability for the investment thesis. There are no immediate signs of financial quality deterioration; the metrics point to a mature, exceptionally profitable, and cash-rich enterprise whose financial strength is not in question, but whose growth engine has stalled. Analysis based on data as of 2024-05-15.